Page last updated: 2024-08-21

cytisine and Disease Models, Animal

cytisine has been researched along with Disease Models, Animal in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Bednarski, J; Mosiewicz, J; Mróz, T; Ognik, J; Styk, A; Tutka, P; Łuszczki, J1
Chan, O; Kirtok, N; LaGamma, EF; Nankova, BB1
Bentham, MP; Blakeman, S; Einstein, EB; Mineur, YS; Newbold, SA; Picciotto, MR; Wigestrand, MB1
Abin-Carriquiry, JA; Cassels, BK; Costa, G; Dajas, F; Rebolledo-Fuentes, M; Urbanavicius, J; Wonnacott, S1
Getachew, B; Hauser, SR; Overstreet, DH; Rezvani, AH; Tizabi, Y1
Rahman, S; Sajja, RK1
Seidler, FJ; Slotkin, TA1
Clark, E; Janowsky, DS; Kling, MA; Louis, VA; Overstreet, DH; Rezvani, AH; Tizabi, Y1

Other Studies

9 other study(ies) available for cytisine and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:1

    Topics: Alkaloids; Animals; Anticonvulsants; Azocines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Injections, Intraperitoneal; Lamotrigine; Male; Mice; Phenytoin; Quinolizines; Seizures; Smoking Cessation; Triazines

2013
Partial blockade of nicotinic acetylcholine receptors improves the counterregulatory response to hypoglycemia in recurrently hypoglycemic rats.
    American journal of physiology. Endocrinology and metabolism, 2014, Oct-01, Volume: 307, Issue:7

    Topics: Adrenal Glands; Alkaloids; Animals; Autonomic Nervous System; Azocines; Blood Glucose; Disease Models, Animal; Epinephrine; Gene Expression Profiling; Glucose Clamp Technique; Hypoglycemia; Male; Nicotinic Antagonists; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recurrence; RNA, Messenger; Tyrosine 3-Monooxygenase

2014
Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alkaloids; Animals; Antidepressive Agents; Azocines; Disease Models, Animal; Drug Synergism; Fluoxetine; Gene Expression Regulation; HEK293 Cells; Hindlimb Suspension; Hippocampus; Humans; Interpersonal Relations; Male; Mice; Mice, Inbred C57BL; Motor Activity; Quinolizines; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Stress, Psychological

2015
In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
    European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

    Topics: Alkaloids; Animals; Antiparkinson Agents; Azocines; Bridged-Ring Compounds; Disease Models, Animal; Dopamine; Male; Microdialysis; Neostriatum; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Receptors, Presynaptic; Substantia Nigra

2008
Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism.
    Progress in neuro-psychopharmacology & biological psychiatry, 2009, Apr-30, Volume: 33, Issue:3

    Topics: Alcoholism; Alkaloids; Analysis of Variance; Animals; Antidepressive Agents; Azocines; Depression; Disease Models, Animal; Drug Administration Schedule; Male; Nicotine; Protein Binding; Quinolizines; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Swimming; Tritium

2009
Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice.
    Pharmacology, biochemistry, and behavior, 2012, Volume: 102, Issue:1

    Topics: Alcohol Drinking; Alkaloids; Animals; Azocines; Behavior, Addictive; Choice Behavior; Dihydro-beta-Erythroidine; Disease Models, Animal; Ethanol; Ligands; Lobeline; Male; Mice; Mice, Inbred C57BL; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Receptors, Nicotinic; Signal Transduction

2012
Cholinergic receptor subtypes in the olfactory bulbectomy model of depression.
    Brain research bulletin, 2006, Jan-30, Volume: 68, Issue:5

    Topics: Alkaloids; Animals; Azocines; Brain; Depression; Disease Models, Animal; Gene Expression Regulation; Male; Muscarinic Antagonists; Olfactory Bulb; Parasympatholytics; Pirenzepine; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Tritium

2006
Antidepressant effects of nicotine in an animal model of depression.
    Psychopharmacology, 1999, Volume: 142, Issue:2

    Topics: Alkaloids; Animals; Antidepressive Agents; Azocines; Binding Sites; Body Temperature; Bungarotoxins; Depression; Disease Models, Animal; Iodine Radioisotopes; Male; Motor Activity; Nicotine; Nicotinic Agonists; Quinolizines; Rats; Receptors, Nicotinic; Tritium

1999